Literature DB >> 20927726

Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.

George G Browning1, Maroeska M Rovers, Ian Williamson, Jørgen Lous, Martin J Burton.   

Abstract

BACKGROUND: Otitis media with effusion (OME; 'glue ear') is common in childhood and surgical treatment with grommets (ventilation tubes) is widespread but controversial.
OBJECTIVES: To assess the effectiveness of grommet insertion compared with myringotomy or non-surgical treatment in children with OME. SEARCH STRATEGY: We searched the Cochrane ENT Disorders Group Trials Register, other electronic databases and additional sources for published and unpublished trials (most recent search: 22 March 2010). SELECTION CRITERIA: Randomised controlled trials evaluating the effect of grommets. Outcomes studied included hearing level, duration of middle ear effusion, language and speech development, cognitive development, behaviour and adverse effects. DATA COLLECTION AND ANALYSIS: Data from studies were extracted by two authors and checked by the other authors. MAIN
RESULTS: We included 10 trials (1728 participants). Some trials randomised children (grommets versus no grommets), others ears (grommet one ear only). The severity of OME in children varied between trials. Only one 'by child' study (MRC: TARGET) had particularly stringent audiometric entry criteria. No trial was identified that used long-term grommets.Grommets were mainly beneficial in the first six months by which time natural resolution lead to improved hearing in the non-surgically treated children also. Only one high quality trial that randomised children (N = 211) reported results at three months; the mean hearing level was 12 dB better (95% CI 10 to 14 dB) in those treated with grommets as compared to the controls. Meta-analyses of three high quality trials (N = 523) showed a benefit of 4 dB (95% CI 2 to 6 dB) at six to nine months. At 12 and 18 months follow up no differences in mean hearing levels were found.Data from three trials that randomised ears (N = 230 ears) showed similar effects to the trials that randomised children. At four to six months mean hearing level was 10 dB better in the grommet ear (95% CI 5 to 16 dB), and at 7 to 12 months and 18 to 24 months was 6 dB (95% CI 2 to 10 dB) and 5 dB (95% CI 3 to 8 dB) dB better.No effect was found on language or speech development or for behaviour, cognitive or quality of life outcomes.Tympanosclerosis was seen in about a third of ears that received grommets. Otorrhoea was common in infants, but in older children (three to seven years) occurred in < 2% of grommet ears over two years of follow up. AUTHORS'
CONCLUSIONS: In children with OME the effect of grommets on hearing, as measured by standard tests, appears small and diminishes after six to nine months by which time natural resolution also leads to improved hearing in the non-surgically treated children. No effect was found on other child outcomes but data on these were sparse. No study has been performed in children with established speech, language, learning or developmental problems so no conclusions can be made regarding treatment of such children.

Entities:  

Mesh:

Year:  2010        PMID: 20927726     DOI: 10.1002/14651858.CD001801.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  46 in total

1.  Autoinflation: an effective nondrug intervention for glue ear.

Authors:  Chris Del Mar; Tammy Hoffmann
Journal:  CMAJ       Date:  2015-07-27       Impact factor: 8.262

2.  The rationale for preventive treatments for early post-tympanostomy tube otorrhea in persistent otitis media with effusion.

Authors:  Mohammad Faramarzi; Sareh Roosta; Mahmood Shishegar; Rohollah Abbasi; Saeid Atighechi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-08       Impact factor: 2.503

3.  Consenting for risk in common ENT operations: an evidence-based approach.

Authors:  M E Smith; R Lakhani; N Bhat
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-23       Impact factor: 2.503

4.  Topical administration of hyaluronic acid in children with recurrent or chronic middle ear inflammations.

Authors:  Sara Torretta; Paola Marchisio; Vittorio Rinaldi; Michele Gaffuri; Carla Pascariello; Lorenzo Drago; Elena Baggi; Lorenzo Pignataro
Journal:  Int J Immunopathol Pharmacol       Date:  2016-06-24       Impact factor: 3.219

5.  [Pedaudiological diagnostics in the first year of life . Clinical follow-up, risk factors, and middle ear function].

Authors:  J W Rumstadt; A am Zehnhoff-Dinnesen; A Knief; D Deuster; P Matulat; K Rosslau; C-M Schmidt
Journal:  HNO       Date:  2012-10       Impact factor: 1.284

Review 6.  [Does balloon dilatation represent a breakthrough for Eustachian tube disorders – even in children?].

Authors:  H W Pau
Journal:  HNO       Date:  2015-10       Impact factor: 1.284

7.  The relationship between preoperative tympanograms and intraoperative ear examination results in children.

Authors:  Steffen Knopke; Ekpemi Irune; Heidi Olze; Florian Bast
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-10       Impact factor: 2.503

8.  Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease.

Authors:  S Torretta; P Marchisio; V Rinaldi; D Carioli; E Nazzari; L Pignataro
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-01       Impact factor: 2.503

9.  Variation in Utilization and Need for Tympanostomy Tubes across England and New England.

Authors:  Devin M Parker; Laura Schang; Jared R Wasserman; Weston D Viles; Gwyn Bevan; David C Goodman
Journal:  J Pediatr       Date:  2016-09-30       Impact factor: 4.406

10.  Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial.

Authors:  Ian Williamson; Jane Vennik; Anthony Harnden; Merryn Voysey; Rafael Perera; Sadie Kelly; Guiqing Yao; James Raftery; David Mant; Paul Little
Journal:  CMAJ       Date:  2015-07-27       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.